TY - JOUR T1 - Wild spirits: Elevated hypomanic tendencies are associated with entrepreneurship and entrepreneurial success JF - medRxiv DO - 10.1101/2020.05.17.20104836 SP - 2020.05.17.20104836 AU - Helen Pushkarskaya AU - Christopher Pittenger AU - Marco Kleine AU - Godfrey Pearlson AU - David R. Just Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/26/2020.05.17.20104836.abstract N2 - Entrepreneurs take extreme risks and make rash decisions but are responsible for innovation, technological change, and economic growth. Attempts to characterize the entrepreneurial personality have had limited success. We hypothesized that elevated hypomanic tendencies (HPM), which have been linked to increased risk for psychopathology, are also associated with entrepreneurship. We tested the association of HPM with entrepreneurial activities cross-sectionally in three different populations (total N = 2,200, including 899 entrepreneurs), using three different measures of hypomanic tendencies. We report a robust positive association of HPM with several measures of entrepreneurial intent, behavior, and success. This may reflect a particular ecological fit between individual characteristics associated with HPM and unique demands of entrepreneurial lifestyle, but highlights the psychological vulnerability of entrepreneurs, especially under conditions of stress.One Sentence Summary A positive relationship between hypomanic tendencies and entrepreneurship is revealed in three large independent datasets.Competing Interest StatementThe authors have declared no competing interest.Funding StatementUSDA National Institute of Food and Agriculture (NIFA) 2011-68006-30807 (to H.P.); National Institutes of Mental Health Grants K01 MH101326-01 (to H.P.); and the State of Connecticut through its support of the Ribicoff Research Facilities at the Connecticut Mental Health Center.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The respective local ethics committees (Institutional Review Board at University of Kentucky, and Yale University Institutional Review Board) approved each study, which were conducted in accordance with the Declaration of Helsinki. The anonymous mailed-in survey (Study 1) was judged to be exempt from informed consent. For computer-based data collection (Study 2 and 3), informed consent form was presented on the first page. Only after participants indicated agreement to participate in the study did they proceed to the surveys.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll de-identified data and R scripts are available at https://github.com/helenpush/HPM.git . https://github.com/helenpush/HPM.git ER -